Helicobacter pylori and benign upper digestive disease
- PMID: 17382276
- DOI: 10.1016/j.bpg.2006.10.002
Helicobacter pylori and benign upper digestive disease
Abstract
Acute infection with Helicobacter pylori causes hypochlorhydria and gastrointestinal upset. As the infection persists, patients develop chronic antral-predominant or pangastritis. Gastric and duodenal ulcers arise from chronic mucosal inflammation and disordered acid secretion in the stomach. With successful eradication of H. pylori, non-NSAID-related gastric and duodenal ulcers heal even without long-term acid suppression. More importantly, peptic ulcers and their complications rarely recur. Clearing H. pylori infection also reduces the risk of mucosal injury in NSAID and aspirin users; the protective effects are more pronounced in NSAID-naïve and aspirin users. H. pylori is unlikely to be the cause of gastro-oesophageal reflux disease. However, a patient's reflux symptoms may be more difficult to control after clearing the infection. Although there is little evidence to support a causal relationship between H. pylori and non-ulcer dyspepsia, treatment of the infection gives a modest improvement of symptoms.
Similar articles
-
Review article: Helicobacter pylori and gastro-oesophageal reflux disease.Aliment Pharmacol Ther. 2005 Aug;22 Suppl 1:32-40. doi: 10.1111/j.1365-2036.2005.02607.x. Aliment Pharmacol Ther. 2005. PMID: 16042657 Review.
-
Helicobacter pylori and non-malignant diseases.Helicobacter. 2006 Oct;11 Suppl 1:27-31. doi: 10.1111/j.1478-405X.2006.00426.x. Helicobacter. 2006. PMID: 16925608 Review.
-
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.Aliment Pharmacol Ther. 2005 Aug 1;22(3):243-9. doi: 10.1111/j.1365-2036.2005.02554.x. Aliment Pharmacol Ther. 2005. PMID: 16091062
-
Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.J Physiol Pharmacol. 2006 Sep;57 Suppl 3:67-79. J Physiol Pharmacol. 2006. PMID: 17033106 Review.
-
Ulcers and gastritis.Endoscopy. 2003 Jan;35(1):9-14. doi: 10.1055/s-2003-36397. Endoscopy. 2003. PMID: 12510220 Review.
Cited by
-
New NCI-N87-derived human gastric epithelial line after human telomerase catalytic subunit over-expression.World J Gastroenterol. 2015 Jun 7;21(21):6526-42. doi: 10.3748/wjg.v21.i21.6526. World J Gastroenterol. 2015. PMID: 26074691 Free PMC article.
-
Comprehensive analysis of Helicobacter pylori infection-associated diseases based on miRNA-mRNA interaction network.Brief Bioinform. 2019 Jul 19;20(4):1492-1501. doi: 10.1093/bib/bby018. Brief Bioinform. 2019. PMID: 29579224 Free PMC article. Review.
-
Ulcerogenic Helicobacter pylori strains isolated from children: a contribution to get insight into the virulence of the bacteria.PLoS One. 2011;6(10):e26265. doi: 10.1371/journal.pone.0026265. Epub 2011 Oct 19. PLoS One. 2011. PMID: 22039453 Free PMC article.
-
BabA-mediated adherence of pediatric ulcerogenic H. pylori strains to gastric mucins at neutral and acidic pH.Virulence. 2018;9(1):1699-1717. doi: 10.1080/21505594.2018.1532243. Virulence. 2018. PMID: 30298790 Free PMC article.
-
Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver Nanoparticles.Pharmaceutics. 2022 Jul 14;14(7):1463. doi: 10.3390/pharmaceutics14071463. Pharmaceutics. 2022. PMID: 35890358 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials